Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volumes used. The aim of this project was to evaluate t...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	NIHR Journals Library 2024-10-01
Edice:	Health Technology Assessment
Témata:	ceftazidime-avibactam colistin drug resistance bacterial anti-bacterial agents cost-effectiveness analysis quality-adjusted life-years network meta-analysis oxacillinase expert testimony microbial sensitivity tests systematic review gram-negative bacterial infections
On-line přístup:	https://doi.org/10.3310/YAPL9347
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!